AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Biodesix, Inc. Common Stock
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG001V0G914
21.18▼ 2.76 (-11.53%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
23.94
Day's Range
21.11 – 23.70
52-Week Range
5.26 – 31.97
Volume
139.3K
Avg Volume
95.7K
Share Statistics
Shares Outstanding
Employees
334
Exchange
XNAS
Listed
2020-10-28
Share count as of July 30, 2026

Biodesix, Inc. Common Stock (BDSX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Biodesix, Inc. Common Stock (BDSX)
What is Biodesix, Inc. Common Stock's Market Cap?
Biodesix, Inc. Common Stock's Market Cap is $223.5M, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's Enterprise Value?
Biodesix, Inc. Common Stock's Enterprise Value is $243.5M, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's Price / Sales?
Biodesix, Inc. Common Stock's Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's EV / Revenue?
Biodesix, Inc. Common Stock's EV / Revenue is 2.4×, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's EV / EBITDA?
Biodesix, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's Revenue (TTM)?
Biodesix, Inc. Common Stock's Revenue (TTM) is $102.9M, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's Net Income (TTM)?
Biodesix, Inc. Common Stock's Net Income (TTM) is -$27.8M, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's EBITDA?
Biodesix, Inc. Common Stock's EBITDA is -$15.0M, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's Diluted EPS (TTM)?
Biodesix, Inc. Common Stock's Diluted EPS (TTM) is -2.63, based on as-reported figures from SEC (XBRL) filings.
What is Biodesix, Inc. Common Stock's EBITDA Margin?
Biodesix, Inc. Common Stock's EBITDA Margin is -14.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BDSXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
YoY growth+34.2%+42.3%+40.8%+19.9%
Operating expenses:
Direct costs and expenses
Research and development
Sales, marketing, general and administrative
Impairment loss on intangible assets
Total operating expenses
% of revenue120.1%124.3%106.8%132.4%
Loss from operations
% of revenue-20.1%-24.3%-6.8%-32.4%
Other (expense) income:
Interest expense
Change in fair value of warrant liability, net—
Other income, net—
Total other expense
Net loss
% of revenue-27.1%-30.5%-13.8%-40.0%
Net loss per share, basic
Net loss per share, diluted